A previous study detected the methylation level of multiple genes in the mucosa from UC-CRC tumors and non-neoplastic colons, and identified the methylated promoters of MINT1, RUNX3 and COX2 as potential signatures of the occurrence of CRC in UC patients (Garrity-Park et al., 2010). This evidence concerns the gene RUNX3 and colorectal carcinoma.